跳至主要内容
临床试验/IRCT201610212017N31
IRCT201610212017N31招募中未知

The effect of Inullin supplementation on expression of KLF5 in Peripheral Blood Mononuclear Cell and pelasma levels miR-375 in patients with type 2 diabetes

Vice-Chancellor for Research of Tabriz University of Medical Sciences0 个研究点目标入组 46 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • inclusion criteria included:The diagnosis of type2 diabetes; aged 30 to 50 years; body mass index greater than 25 and less than 35
  • Exclusion criteria included: kidney disease; liver failure; heart failure; rheumatic diseases inflammatory diseases of the gastrointestinal tract; lactose intolerance; insulin injection and drugs Consumption: estrogen, progesterone, corticosteroids; smoking; breast feeding and pregnancy; vitamin, minerals,omega-3 and antibiotics supplementation for three weeks before the start of the study

排除标准

  • 未提供

研究者

发起方
Vice-Chancellor for Research of Tabriz University of Medical Sciences

相似试验

The effect of Inullin supplementation on expression... | 临床试验